Genolution Inc. (225220) - Total Liabilities

Latest as of September 2025: ₩26.44 Billion KRW ≈ $17.92 Million USD

Based on the latest financial reports, Genolution Inc. (225220) has total liabilities worth ₩26.44 Billion KRW (≈ $17.92 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Genolution Inc. operating cash flow efficiency to assess how effectively this company generates cash.

Genolution Inc. - Total Liabilities Trend (2016–2024)

This chart illustrates how Genolution Inc.'s total liabilities have evolved over time, based on quarterly financial data. Check Genolution Inc. (225220) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Genolution Inc. Competitors by Total Liabilities

The table below lists competitors of Genolution Inc. ranked by their total liabilities.

Company	Country	Total Liabilities
Leaders Cosmetics Co. Ltd KQ:016100	Korea	₩40.13 Billion
Wing Yip Food Holdings Group Limited American Depositary Shares NASDAQ:WYHG	USA	$42.79 Million
Teaminvest Private Group Ltd AU:TIP	Australia	AU$46.12 Million
Sintercom India Limited NSE:SINTERCOM	India	Rs968.38 Million
Pulsenmore Ltd TA:PULS	Israel	ILA45.83 Million
Indofarma Tbk JK:INAF	Indonesia	Rp1.47 Trillion
Cadence Opportunities Fund Ltd AU:CDO	Australia	AU$13.30 Million
Gryphon Digital Mining Inc. NASDAQ:GRYP	USA	$17.19 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Genolution Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Genolution Inc. market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.48	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.36	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Genolution Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Genolution Inc. (2016–2024)

The table below shows the annual total liabilities of Genolution Inc. from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩26.16 Billion ≈ $17.73 Million	+0.68%
2023-12-31	₩25.99 Billion ≈ $17.61 Million	+31.55%
2022-12-31	₩19.75 Billion ≈ $13.39 Million	+55.08%
2021-12-31	₩12.74 Billion ≈ $8.63 Million	-43.34%
2020-12-31	₩22.48 Billion ≈ $15.24 Million	+108.37%
2019-12-31	₩10.79 Billion ≈ $7.31 Million	+32.26%
2018-12-31	₩8.16 Billion ≈ $5.53 Million	+1058.74%
2017-12-31	₩704.01 Million ≈ $477.10K	+23.38%
2016-12-31	₩570.62 Million ≈ $386.70K	--

About Genolution Inc.

KQ:225220 Korea Biotechnology

Market Cap

$22.90 Million

₩33.78 Billion KRW

Market Cap Rank

#24585 Global

#1815 in Korea

Share Price

₩1870.00

Change (1 day)

-0.95%

52-Week Range

₩1616.00 - ₩2645.00

All Time High

₩10300.23